Differential systemic inflammatory responses after TAVI: The role of self versus balloon expandable devices

PLoS One. 2021 Oct 26;16(10):e0258963. doi: 10.1371/journal.pone.0258963. eCollection 2021.

Abstract

Objective: Transcatheter aortic valve implantation (TAVI) provokes early injury response, represented in part by dynamic changes in the inflammatory markers. The association of self-expanding valves (SEVs) and balloon-expandable valves (BEVs) with the consequent inflammatory response remains uncertain.

Materials and methods: Patients with severe symptomatic aortic stenosis who underwent transfemoral TAVI: SEVs or BEVs, from January 2010 to December 2019 were enrolled. Whole white blood cells (WBC) and subpopulation dynamics as well the neutrophil to lymphocyte ratio (NLR) were evaluated.

Results: Three-hundred seventy consecutive patients (mean age 81.75 ± 6.8 years, 199 women's) were enrolled. In the entire population, significant kinetic changes in the WBC response (p <0.0001) between admission and first 24 hours post procedure, with a significant increase in total WBC (7.46 ± 2.26 to 10.08 ± 3.55) and absolute neutrophil count (4.97 ± 2.06 to 8.19 ± 3.43), NL ratio (3.72 ± 2.8 to 9.76 ± 7.29), and a meaningful decrease in absolute lymphocytes count (1.67 ± 1.1 to 1.1 ± 0.76). When compared between the types of valves, SEVs were associated with a more pronounced inflammatory response than BEVs, with total WBC (10.44 ± 3.86 vs. 9.45 ± 3.19) neutrophils (8.56 ± 3.75 vs. 7.55 ± 3.06) with p 0.016 and 0.012 respectively.

Conclusion: This is the first description of a differential inflammatory response between the two leading delivery systems. SEV appears to trigger a more robust inflammatory response as compared to BEV. Clinical studies are warranted to assess the long term effect of our findings.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Aortic Valve Stenosis / blood
  • Aortic Valve Stenosis / surgery*
  • Female
  • Heart Valve Prosthesis*
  • Humans
  • Inflammation / blood
  • Inflammation / etiology*
  • Lymphocytes
  • Male
  • Neutrophils
  • Postoperative Complications / blood
  • Postoperative Complications / etiology
  • Transcatheter Aortic Valve Replacement / adverse effects*
  • Treatment Outcome

Grants and funding

The author(s) received no specific funding for this work.